Animal model of sclerotic skin. III: Histopathological comparison of bleomycin-induced scleroderma in various mice strains

Archives of Dermatological Research

Volumn 292, Issue 11, 2000, Pages 535-541

  Yamamoto, T ^a   Kuroda, Mieko ^a   Nishioka, Kiyoshi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Bleomycin; Mouse model; Scleroderma

Indexed keywords

BLEOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG INDUCED DISEASE; FIBROBLAST; HISTOPATHOLOGY; LUNG FIBROSIS; LYMPHOCYTIC INFILTRATION; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SCLERODERMA; STRAIN DIFFERENCE;

ANIMALS; BLEOMYCIN; COLLAGEN; DISEASE MODELS, ANIMAL; EPIDERMIS; FEMALE; GENE EXPRESSION REGULATION; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, INBRED STRAINS; RNA, MESSENGER; SCLERODERMA, SYSTEMIC; SKIN; SPECIES SPECIFICITY; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 0034536258     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004030000183     Document Type: Article

References (20)

1. Systemic scleroderma. Clinical and pathophysiological aspects
2. A brief overview of the pathogenesis of scleroderma (systemic sclerosis)
3. Connective tissue alterations in systemic sclerosis
4. Animal models of systemic sclerosis
5. New antibiotics, bleomycin A and B
6. Bleomycin-induced scleroderma
7. The pathogenesis of bleomycin-induced pulmonary fibrosis
8. Morphological and biological study of pulmonary changes induced by bleomycin in mice
9. Possible mechanisms of bleomycin-induced fibrosis
10. Bleolnycin-induced synthesis of type I procollagen by human lung skin fibroblasts in culture
11. Bleomycin selectively elevates mRNA levels for procollagen and fibronectin following acute lung injury
12. Animal model of sclerotic skin. I: Local injections of bleomycin induce dermal sclerosis mimicking scleroderma
13. Animal model of sclerotic skin. II: Bleomycin-induced scleroderma in genetically mast cell-deficient WBB6F1W/W(v)mice
14. The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid
15. Increased dermal mast cell populations in progressive systemic sclerosis: A link in chronic fibrosis?
16. Mast cell numbers in diffuse scleroderma
17. Mast cells: Accessory cells which potentiate fibrosis
18. Cutaneous toxicity of bleomycin therapy
19. Dermatologic changes after systemic cancer therapy
20. Flagellate pigmentation for intrapleural bleomycin